普通科門診公私營協作計劃(門診協作)
現時於醫管局門診診所接受治理而符合指定臨床及計劃準則,並至少12個月前開始接受治理的病人會被邀請參加計劃,到社區內接受私營基層醫療服務。

e-Bulletin

Issue 37 - Increase in Programme Drugs Orderable Quantity (只提供英文版本)

2020年10月14日
Dear Doctors,

Thank you for your participation and continued support to the Programme. Upon receiving feedback from some Participating Service Providers (PSPs) concerning the continuity supply of drugs for Programme patients, we are pleased to inform you that the orderable quantity for the following three Programme Drugs will be increased with effect from 23 October 2020. You may access the drug ordering platform on eHRSS to check the updated balance.

Drug Item Calculation Basis for the Orderable Quantity
Famotidine Tablet 20mg From 20mg daily to 20mg BD
Metformin HCI Tablet 500mg From 500mg TDS to 1000mg BD
Amlodipine (Besylate) Tablet 5mg From 5mg daily to 7.5mg daily

Please be reminded that the orderable quantities of Programme Drugs are varied by the no. of enrolled patients prescribed with the drug item. In this regard, timely input of prescription records in the GOPC PPP Profile is essential for you to be able to see the most updated quantity of drug that could be ordered.

Should you have any queries, please feel free to contact us at gopcppp@ha.org.hk or via Programme hotline 2300 7300 for assistance (after selecting language, press “5” to speak directly with our hotline staff). Thank you for your attention.

Yours faithfully,
GOPC PPP Programme Office
Hospital Authority